Faster, cheaper PET scans using thallium chloride detector crystals
TOF-PET with high-efficiency TlCl crystals
Researchers are developing new detector crystals to make PET scans faster, clearer, and less expensive for people needing cancer or heart imaging.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11324303 on NIH RePORTER |
What this research studies
This project is developing new detector crystals (thallium chloride, or TlCl) that produce a very fast light signal when they detect PET tracers. The team will dope TlCl with small amounts of elements like beryllium and indium to create a very fast scintillation component (~10 ns) and improve timing accuracy. That could allow PET scanners to pinpoint signals better, enable lower-radiation or cell-tracking imaging, and cut detector costs compared with current LYSO-based systems. Work involves laboratory crystal growth, optical and timing measurements, and prototype imaging tests at UC Davis before any clinical use.
Who could benefit from this research
Good fit: People who need PET imaging for cancer staging, recurrence monitoring, or cardiovascular evaluation, or who might be interested in future low-dose or cell-tracking imaging, are the most likely to benefit.
Not a fit: Patients whose diagnosis and care do not involve PET imaging (for example, those managed only with blood tests or MRI) are unlikely to see direct benefits in the near term.
Why it matters
Potential benefit: If successful, this could make PET scans faster, more sensitive, and less expensive, enabling wider access and safer low-dose imaging options.
How similar studies have performed: Current commercial PET scanners use LYSO crystals with good timing, but using TlCl is a newer approach with promising preliminary lab results rather than established clinical success.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Arino Estrada, Gerard — University of California at Davis
- Study coordinator: Arino Estrada, Gerard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.